Health Care Equipment & Services

CVS Health’s latest share‑holding shift signals investors eyeing PBM, specialty‑drug, and digital‑pharmacy trends amid rising competition and regulatory scrutiny.

Veeva Systems launches a $2 billion share buyback, boosting EPS and reinforcing its cash‑rich, cloud‑based platform for life‑science firms.

PetVivo Holdings: niche veterinary biotech firm with high P/B, negative P/E, volatile OTC stock—investors weigh potential gains against financial uncertainty.

Integer Holdings faces a surge of investor lawsuits alleging securities fraud—discover how you can protect your shares and the impact on its $2.69 B valuation.

Agilon Health faces multiple investor lawsuits alleging securities‑fraud, with several law firms urging action. Understand the risks, legal impact, and how it may affect AGL’s stock price.

Therma Bright Inc. develops thermal therapy devices for insect stings and cold sores while backing inhaled statin research for COPD, offering potential growth in healthcare innovation.

Explore Clover Health’s Nasdaq stock, its Medicare Advantage strategy, recent 11.6% dip, and valuation signals—learn why investors eye future growth.

How Lantheus’s SPECT sale to Shine reshapes the $19 bn nuclear medicine market, boosts Shine’s cardiac imaging reach, and signals a broader med‑tech focus shift.

Discover why Evolent Health’s stock dipped below its 50‑day moving average, its valuation surprises, and how its value‑based care platform still drives innovation in healthcare technology.

Explore how PAVmed’s reverse stock split aims to boost its share price, strengthen investor confidence, and keep its focus on cutting‑edge medical devices in the competitive healthcare equipment industry.